ScholarIQanswers from OpenAlex
Yale Cancer Center
InstitutionResearch output, impact & collaborations
Yale Cancer Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about Yale Cancer Center?
ScholarIQrecord summary
Yale Cancer Center is a research organisation in New Haven, US. OpenAlex records 12,409 works and 1,376,819 citations for it. 1,862 researchers list it as their most recent affiliation.
How many works does Yale Cancer Center have?
ScholarIQindexed works
Yale Cancer Center has 12,409 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yale Cancer Center have?
ScholarIQcitation count
Yale Cancer Center has 1,376,819 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Yale Cancer Center?
ScholarIQresearcher count
Yale Cancer Center has 1,862 researchers in the ScholarIQ index.
What is the average h-index at Yale Cancer Center?
ScholarIQavg h-index
Yale Cancer Center has an average h-index of 83.5 in OpenAlex.
What is the ROR of Yale Cancer Center?
ScholarIQror
The ROR for Yale Cancer Center is on the source record.
What is the OpenAlex record for Yale Cancer Center?
ScholarIQopenalex
The OpenAlex for Yale Cancer Center is on the source record.
What is the Wikidata of Yale Cancer Center?
ScholarIQwikidata
The Wikidata for Yale Cancer Center is on the source record.
Who are the most-cited researchers behind Yale Cancer Center?
ScholarIQtop researchers by citations
What are the most-cited papers on Yale Cancer Center?
ScholarIQmost cited works
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure–Kunkel, Shruti Agrawal, D. G. McDonald, Georgia Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J. Kaye, Neal I. Lindeman, Titus J. Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J. Eck, William R. Sellers, Bruce E. Johnson, Matthew Meyerson
Compendium of Physical Activities: an update of activity codes and MET intensities
Barbara E. Ainsworth, William L. Haskell, Melicia C. Whitt, Melinda L. Irwin, Ann M. Swartz, Scott J. Strath, WILLIAM L. O BRIEN, David R. Bassett, Kathryn H. Schmitz, PATRICIA O. EMPLAINCOURT, David R. Jacobs, Arthur S. Leon
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled‐Filhart, Edward B. Garon
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi
How much of the research on Yale Cancer Center is open access?
ScholarIQopen access share
75%OPEN ACCESS